Skip to content

Medical device manufacturer

Behring Diagnostics, Inc.

Behring Diagnostics, Inc. holds 145 FDA 510(k) clearances across 80 product codes. Median elapsed review time is 70 days. openFDA lists no recall records naming the company.

Updated · ingest status · JSON

510(k) clearances
145
Product codes
80
Median review
70 days
Recall records
0

How does FDA spell Behring Diagnostics, Inc.?

FDA publishes this company under a single spelling, so nothing needed merging here. Many manufacturers are not so tidy.

Which product codes does Behring Diagnostics, Inc. file in?

80 product codes, ranked by how much they file in each.

Product codes this company holds clearances in, with their median elapsed review time in each.
CodeDeviceClearancesMedian reviewLatest
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)727 days
DHRSystem, Test, Rheumatoid Factor552 days
GGPTest, Qualitative And Quantitative Factor Deficiency5136 days
JJQColorimeter, Photometer, Spectrophotometer For Clinical Use575 days
JJYMulti-Analyte Controls, All Kinds (Assayed)558 days
JPASystem, Multipurpose For In Vitro Coagulation Studies5106 days
LFZEnzyme Linked Immunoabsorbent Assay, Cytomegalovirus5192 days
JIXCalibrator, Multi-Analyte Mixture425 days
JZWNephelometer420 days
DCKC-Reactive Protein, Antigen, Antiserum, And Control326 days
DDRMyoglobin, Antigen, Antiserum, Control323 days
GGCControl, Plasma, Abnormal3540 days
GJTPlasma, Coagulation Factor Deficient3263 days
GTQAntistreptolysin - Titer/Streptolysin O Reagent3160 days
JZGSystem, Test, Beta-2-Microglobulin Immunological3203 days
CFNMethod, Nephelometric, Immunoglobulins (G, A, M)236 days
CIJSaccharogenic, Amylase215 days
CZWComplement C3, Antigen, Antiserum, Control241 days
DBFFerritin, Antigen, Antiserum, Control240 days
DCFAlbumin, Antigen, Antiserum, Control210 days
DCNSystem, Test, C-Reactive Protein29 days
DHNAntinuclear Antibody, Indirect Immunofluorescent, Antigen, Control236 days
GFOActivated Partial Thromboplastin2142 days
GGNPlasma, Coagulation Control292 days
GILPlasma, Fibrinogen Control238 days

Showing the 25 they file in most, of 80.

Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Has Behring Diagnostics, Inc. had a recall?

openFDA lists no recall records naming this company. That is the absence of a record, not a guarantee — and it counts only recalls FDA has published under a spelling we resolved to this company.

Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.

Source: openFDA device/recall · retrieved

What has Behring Diagnostics, Inc. cleared recently?

Most recent 510(k) clearances for this company, newest first.
510(k)DeviceCodeDecisionElapsed days
K973832OPUS HLH CONTROLSJJX20
K972929N ANTISERUM TO HUMAN ALBUMINDCF73
K972840N ANTISERUM TO HUMAN TRANSFERRINDDG77
K973202MODIFICATION OF OPUS FERRITIN TEST SYSTEMDBF66
K972316OPUS D-DIMERGHH81
K972116VON WILLEBRAND REAGENTGGP50
K972011OPUS ETHANOLDIC53
K971600EMIT CALIBRATOR B LEVEL 1 (CUTOFF)/EMIT CALIBRATOR B LEVEL 2 (HIGH)DKB55
K971596EMIT II OPIATES 300/2000 ASSAYDJG55
K964595OPUS PSA TEST SYSTEMLTJ218

Source: openFDA device/510k · retrieved

Watch what Behring Diagnostics, Inc. files next

Get an email when this company clears a new device, or when anything is recalled in a product code you follow.

Start watching with DeviceSignal

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.